Directory
>
Daniel Vitt
Daniel Vitt
Chief Executive Officer | Immunic Therapeutics
Munich, Bavaria, Germany
Daniel Vitt
Summary
Daniel Vitt is a seasoned Chief Executive Officer and serial entrepreneur with extensive experience in the biotechnology sector. He has a robust background in drug development, particularly in the fields of Inflammation and Oncology. With a PhD in Organic Chemistry from the University of Würzburg, he has honed his skills in cheminformatics and molecular biology. Daniel co-founded 4SC and served as its Chief Scientific Officer for nearly two decades, showcasing his long-term commitment to the industry. Currently, he leads Immunic Therapeutics in developing innovative therapies for chronic inflammatory and autoimmune diseases. His leadership is characterized by a blend of scientific expertise and business acumen, positioning him as a pivotal figure in the biotechnology landscape. Fluent in the intricacies of drug discovery, he is passionate about advancing therapeutic solutions that address unmet medical needs.
Daniel Vitt
Work Experience
Chief Executive Officer at
Immunic Therapeutics
January 2017 - Present
CSO and CDO at
4SC AG
August 1997 - December 2016
Daniel Vitt
Education
The Julius Maximilians University of Würzburg, Dr.
January 1991 - January 1997
Universität Siegen
January 1989 - January 1991
FJM Siegen
January 1979 - January 1987
Frequently Asked Questions about Daniel Vitt
What is Daniel Vitt email address?
Daniel Vitt's primary email address is ***********@imux.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Daniel Vitt work for?
Daniel Vitt is a Chief Executive Officer at Immunic Therapeutics, a company specializing in Commercial physical research.
Where Daniel Vitt graduated from?
Daniel Vitt holds a degree in Organic Chemistry from The Julius Maximilians University of Würzburg.
How can I directly contact Daniel Vitt?
To contact Daniel Vitt directly, you can use the email address ***********@imux.com. Complete contact information is available upon registration with Muraena.
Who is Daniel Vitt?
Daniel Vitt is a seasoned Chief Executive Officer and serial entrepreneur with extensive experience in the biotechnology sector. He has a robust background in drug development, particularly in the fields of Inflammation and Oncology. With a PhD in Organic Chemistry from the University of Würzburg, he has honed his skills in cheminformatics and molecular biology. Daniel co-founded 4SC and served as its Chief Scientific Officer for nearly two decades, showcasing his long-term commitment to the industry. Currently, he leads Immunic Therapeutics in developing innovative therapies for chronic inflammatory and autoimmune diseases. His leadership is characterized by a blend of scientific expertise and business acumen, positioning him as a pivotal figure in the biotechnology landscape. Fluent in the intricacies of drug discovery, he is passionate about advancing therapeutic solutions that address unmet medical needs.
Daniel`s contact details
***********@imux.com
Colleagues
Chief Financial Officer
Executive Chairman
Vice President Investor Relations and Communications
Chief Development Officer (CDO)